MCID: MCN007
MIFTS: 39

Meconium Aspiration Syndrome malady

Categories: Rare diseases, Fetal diseases, Respiratory diseases

Aliases & Classifications for Meconium Aspiration Syndrome

About this section
Sources:
10Disease Ontology, 45NIH Rare Diseases, 47Novoseek, 12DISEASES, 51Orphanet, 36MeSH, 65UMLS, 27ICD10, 42NCIt, 59SNOMED-CT, 28ICD10 via Orphanet, 37MESH via Orphanet, 66UMLS via Orphanet
See all MalaCards sources

Aliases & Descriptions for Meconium Aspiration Syndrome:

Name: Meconium Aspiration Syndrome 10 45 47 12 51 36 65
Neonatal Aspiration of Meconium 10
Macrophage Activation Syndrome 65
 
Meconium Aspiration 10
Mas 45

Characteristics:

Orphanet epidemiological data:

51
meconium aspiration syndrome:
Inheritance: Not applicable; Prevalence: 1-9/100000 (Europe); Age of onset: Infancy,Neonatal

Classifications:



External Ids:

Disease Ontology10 DOID:11049
MeSH36 D008471
NCIt42 C87093
Orphanet51 70588
ICD10 via Orphanet28 P24.0
MESH via Orphanet37 D008471
UMLS via Orphanet66 C0025048
UMLS65 C0025048, C1096155

Summaries for Meconium Aspiration Syndrome

About this section
NIH Rare Diseases:45 Meconium aspiration syndrome is a serious condition in which a newborn breathes a mixture of meconium and amniotic fluid into the lungs around the time of delivery. this can cause breathing difficulties due to swelling (inflammation) in the baby's lungs after birth. treatment may include suctioning the newborn's mouth as soon as the head emerges during delivery, deep suctioning of the windpipe, antibiotics to treat infection, oxygen to keep blood levels normal, and radiant heat to maintain body temperature. in severe cases, the baby may need assistance breathing (ventilator). last updated: 1/12/2012

MalaCards based summary: Meconium Aspiration Syndrome, also known as neonatal aspiration of meconium, is related to atherosclerosis and heart disease. An important gene associated with Meconium Aspiration Syndrome is EDN1 (Endothelin 1), and among its related pathways are Prostaglandin Synthesis and Regulation and Pancreatic secretion. Affiliated tissues include lung, uterus and t cells.

Wikipedia:68 Meconium aspiration syndrome (MAS) also known as neonatal aspiration of meconium is a medical condition... more...

Related Diseases for Meconium Aspiration Syndrome

About this section

Graphical network of the top 20 diseases related to Meconium Aspiration Syndrome:



Diseases related to meconium aspiration syndrome

Symptoms for Meconium Aspiration Syndrome

About this section

Drugs & Therapeutics for Meconium Aspiration Syndrome

About this section

Drugs for Meconium Aspiration Syndrome (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 27)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
MisoprostolapprovedPhase 426559122-46-25282381
Synonyms:
(+/-)-15-Deoxy-(16RS)-16-hydroxy-16-methylprostaglandin E1 methyl ester
(11-alpha,13E)-(+-)-11,16-Dihydroxy-16-methyl-9-oxoprost-13-en-1-oic acid methyl ester
59122-46-2
62015-39-8
AC1NQZZA
Ambap103601-27-0
Arthrotec
BRN 4155643
CCRIS 6859
CHEMBL606
CID5282381
Cytotec
Cytotec (TN)
D00419
DB00929
GyMiso
HMS2090L10
HSDB 3573
I14-11712
Isprelor
 
M6807_SIGMA
MLS000028863
Methyl (+-)-11-alpha,16-dihydroxy-16-methyl-9-oxoprost-13-en-1-oate
Misopess
Misoprostol
Misoprostol (JAN/USAN/INN)
Misoprostolum
Misoprostolum [INN-Latin]
Misotol
MolPort-003-666-830
NCGC00162445-01
NCGC00162445-02
SC 29333
SC-29333
SMP1_000193
SMR000058558
UNII-0E43V0BB57
XP-16J
methyl (11alpha,13E)-11,16-dihydroxy-16-methyl-9-oxoprost-13-en-1-oate
methyl 7-[(1R,2R,3R)-3-hydroxy-2-[(E)-4-hydroxy-4-methyloct-1-enyl]-5-oxocyclopentyl]heptanoate
misoprostol
2Pulmonary SurfactantsPhase 4, Phase 3101
3Respiratory System AgentsPhase 4, Phase 33931
4Sildenafil CitratePhase 4304171599-83-0
5Vasodilator AgentsPhase 4, Phase 3, Phase 22926
6Pharmaceutical SolutionsPhase 47004
7Phosphodiesterase InhibitorsPhase 41062
8Phosphodiesterase 5 InhibitorsPhase 4513
9Gastrointestinal AgentsPhase 46401
10Anti-Ulcer AgentsPhase 41453
11AntacidsPhase 41453
12Poractant alfaPhase 423
13
Citric AcidnutraceuticalPhase 4100177-92-9311
Synonyms:
2-Hydroxy-1,2,3-propanetricarboxylate
2-Hydroxy-1,2,3-propanetricarboxylic acid
2-Hydroxytricarballylic acid
3-Carboxy-3-hydroxypentane-1,5-dioate
3-Carboxy-3-hydroxypentane-1,5-dioic acid
Aciletten
Anhydrous citrate
Anhydrous citric acid
Chemfill
Citraclean
 
Citrate
Citretten
Citric acid
Citro
Citronensäure
E 330
Hydrocerol A
Kyselina citronova
Suby G
Uro-trainer
beta-Hydroxytricarballylate
beta-Hydroxytricarballylic acid
14CitrateNutraceuticalPhase 41001
15
Nitric OxideapprovedPhase 356410102-43-9145068
Synonyms:
(.)NO
(NO)(.)
10102-43-9
14332-28-6
295566_ALDRICH
51005-20-0
51005-21-1
53851-19-7
90452-29-2
AC1L1ADQ
AC1L3QHF
AC1Q6QZ0
AR-1K7463
Bioxyde d'azote
Bioxyde d'azote [French]
C00533
CCRIS 4319
CHEMBL1200689
CHEMBL1234765
CID145068
CID945
D00074
D009569
DB00435
EDRF
EINECS 233-271-0
Endogenous Nitrate Vasodilator
Endothelium-Derived Nitric Oxide
HNO
HSDB 1246
INOmax
INOmax (TN)
Inomax
LS-192158
LS-7547
MolPort-003-929-452
Mononitrogen monoxide
Monoxide, Mononitrogen
Monoxide, Nitrogen
Monoxido de nitrogeno
Monoxyde d'azote
NITRIC-OXIDE
NO
NO(.)
Nitrate Vasodilator, Endogenous
Nitric Oxide, Endothelium Derived
 
Nitric Oxide, Endothelium-Derived
Nitric oxide
Nitric oxide (JAN)
Nitric oxide 10% by volume or more
Nitric oxide trimer
Nitric oxide, compressed [UN1660] [Poison gas]
Nitric oxide, compressed [UN1660] [Poison gas]
Nitrogen monoxide
Nitrogen oxide
Nitrogen oxide (NO)
Nitrogen protoxide
Nitrosyl
Nitrosyl hydride
Nitrosyl hydride ((NO)H)
Nitrosyl radical
Nitroxide radical
Nitroxyl
OHM 11771
Oxide, Nitric
Oxido de nitrogeno(ii)
Oxido nitrico
Oxyde azotique
Oxyde nitrique
Oxyde nitrique [French]
RCRA waste no. P076
Stickmonoxyd
Stickmonoxyd [German]
Stickstoff(II)-oxid
Stickstoff(ii)-oxid
Stickstoffmonoxid
UN 1660
UN1660
UNII-31C4KY9ESH
Vasodilator, Endogenous Nitrate
[NO]
endothelium-derived relaxing factor
monoxido de nitrogeno
monoxyde d'azote
nitric oxide
nitrogen monooxide
nitrogen monoxide
nitrosyl
oxido de nitrogeno(II)
oxido nitrico
oxidonitrogen(.)
oxoazanyl
oxyde azotique
16Peripheral Nervous System AgentsPhase 318510
17Protective AgentsPhase 35651
18Endothelium-Dependent Relaxing FactorsPhase 3225
19Neurotransmitter AgentsPhase 314795
20Bronchodilator AgentsPhase 32377
21Anti-Asthmatic AgentsPhase 32796
22Vasoconstrictor AgentsPhase 31303
23AntioxidantsPhase 32442
24
Oxytocinapproved36650-56-6439302, 53477758
Synonyms:
(2S)-1-[(4R,7S,10S,13S,16S,19R)-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-[(2S)-butan-2-yl]-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl]-N-[(2S)-1-[(2-amino-2-oxoethyl)amino]-4-methyl-1-oxopentan-2-yl]pyrrolidine-2-carboxamide
(Arg8)-Vasopressin
(Arg8)-Vasotocin
1-({(4R,7S,10S,13S,16S,19R)-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-16-(4-hydroxybenzyl)-13-[(1S)-1-methylpropyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-4-yl}carbonyl)-L-prolyl-L-leucylglycinamide
50-56-6
AC1L9735
Argipressin
Argpressin Acetate
BCBcMAP01_000094
Biotinyl-(Arg8)-Vasopressin
C00746
CHEBI:492195
CHEBI:7872
CHEMBL395429
CID439302
Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Arg-Gly-NH2
Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Leu-Gly-NH2
Cys-Tyr-Ile-Thr-Asn-Cys-Gly-Leu-Gly-NH2
Cys-Tyr-Phe-Gln-Asn-Cys-Pro-Arg-Gly-NH2
Cys-Tyr-Phe-Gln-Asn-Cys-Pro-Lys-Gly-NH2
D00089
Disulfide bridge Cys1-Cys6
Gly-Leu-Pro-c
HS-2021
L-Cysteinyl-L-tyrosyl-L-isoleucyl-L-glutaminyl-L-asparaginyl-L-cysteinyl-L-prolyl-L-leucylglycinamide cyclic(1-6)-disulfide
MolPort-003-938-941
 
NCGC00167132-01
O3251_SIGMA
O4375_SIGMA
OXT
OXYTOCIN
Ocytocin
Oxitocina
Oxytocic hormone
Oxytocin
Oxytocin (JP15/USP/INN)
Oxytocin (TN)
Oxytocin 10 Usp Units In Dextrose 5%
Oxytocin 20 Usp Units In Dextrose 5%
Oxytocin 5 Usp Units In Dextrose 5%
Oxytocin Acetate
Oxytocin injection
Oxytocine
Oxytocinum
Pitocin
Pitocin (TN)
SID29217903
SID50111741
Syntocinon
Syntocinon (TN)
TI-001
alpha-Hypophamine
nchembio.184-comp2
25
Dinoprostoneapproved74363-24-65280360
Synonyms:
(-)-Prostaglandin E2
(15S)-Prostaglandin E2
(15S)-Prostaglandin e2
(5Z,11-alpha,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid
(5Z,11.alpha.,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid
(5Z,11alpha,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic
(5Z,11alpha,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dienoic acid
(5Z,11alpha,13E,15S)-11,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid
(5Z,11alpha,13e,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid
(5Z,13E)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate
(5Z,13E)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoic acid
(5Z,13E)-(15S)-11alpha,15-Dihydroxy-9-oxoprosta-5,13-dienoate
(5Z,13E)-(15S)-11alpha,15-Dihydroxy-9-oxoprosta-5,13-dienoic acid
(5Z,13E)-(15S)-11alpha,15-dihydroxy-9-oxoprosta-5,13-dienoate
(5Z,13E,15S)-11-alpha,15-dihydroxy-9-oxoprost-5,13-dienoate
(5Z,13E,15S)-11-alpha,15-dihydroxy-9-oxoprost-5,13-dienoic acid
(5Z,13E,15S)-11alpha,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid
(5Z,13e)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate
(5Z,13e)-(15S)-11alpha,15-Dihydroxy-9-oxoprosta-5,13-dienoate
(E,Z)-(1R,2R,3R)-7-(3-Hydroxy-2-((3S)-(3-hydroxy-1-octenyl))-5-oxocyclopentyl)-5-heptenoic acid
(Z)-7-((1R,2R,3R)-3-Hydroxy-2-((S,e)-3-hydroxyoct-1-enyl)-5-oxocyclopentyl)hept-5-enoic acid
(Z)-7-[(1R,2R,3R)-3-Hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-5-oxocyclopentyl]hept-5-enoic acid
(e,Z)-(1R,2R,3R)-7-(3-Hydroxy-2-((3S)-(3-hydroxy-1-octenyl))-5-oxocyclopentyl)-5-heptenoic acid
05D31BD5-818B-4A92-8CFC-BEC19926A5B3
363-24-6
5-Heptenoic acid, 7-(3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)- (8CI)
5-trans-PGE2
7-(3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)-5-heptenoic acid
AC-6098
AC1NQWXW
BML1-F07
BMS-279654 & PGE2
BRD-K26521938-001-04-9
BSPBio_001490
C00584
CHEBI:15551
CHEMBL548
CID5280360
Cervidil
Cervidil (TN)
D00079
D015232
DB00917
Dinoproston
Dinoprostona
Dinoprostona [INN-Spanish]
Dinoprostone
Dinoprostone (JAN/USP/INN)
Dinoprostone Prostaglandin E2
Dinoprostone [USAN:INN:BAN:JAN]
Dinoprostone beta-Cyclodextrin Clathrate
Dinoprostonum
Dinoprostonum [INN-Latin]
E2 alpha, Prostaglandin
E2, Prostaglandin
E2alpha, Prostaglandin
 
EINECS 206-656-6
Gel, Prepidil
Glandin
HMS1361K12
HMS1791K12
HMS1989K12
HMS2089D17
IDI1_033960
L-Prostaglandin E2
LMFA03010003
LS-125823
Minprositin E2
Minprostin E2
MolPort-003-939-184
NCGC00092361-01
NCGC00092361-02
NCGC00092361-03
NCGC00092361-04
NCGC00092361-05
NSC 165560
NSC 196514
P0409_SIGMA
P5640_SIGMA
P6532_SIGMA
PGE2
PGE2 alpha
PGE2alpha
Prepidil
Prepidil (TN)
Prepidil Gel
Prestwick_793
Propess
Prostaglandin E
Prostaglandin E2
Prostaglandin E2 alpha
Prostaglandin E2alpha
Prostarmon E
Prostarmon E2
Prostenon
Prostin
Prostin E
Prostin E2
Prostin E2 (TN)
Prostin e2
SMP2_000056
ST50826265
U 12062
U-12062
UNII-K7Q1JQR04M
[3H]PGE2
alpha, PGE2
alpha, Prostaglandin E2
l-7-(3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)-5-heptenoic acid
l-PGE2
l-Prostaglandin E2
nchembio.106-comp6
nchembio.147-comp12
26Immunoglobulins4477
27Antibodies4477

Interventional clinical trials:

(show all 20)
idNameStatusNCT IDPhase
1Oral Sildenafil in Persistent Pulmonary Hypertension Secondary to Meconium Aspiration Syndrome in NewbornsCompletedNCT01757782Phase 4
2Lung Lavage With Dilute Poractant Alfa for Meconium Aspiration SyndromeRecruitingNCT02041546Phase 4
3Cervical Ripening for Obese Women: A Randomized, Comparative Effectiveness TrialRecruitingNCT02639429Phase 4
4Surfactant Lavage vs. Bolus Surfactant in Neonates With Meconium AspirationRecruitingNCT00312507Phase 3
5Phase III Randomized Study of Lucinactant in Full Term Newborn Infants With Meconium Aspiration SyndromeTerminatedNCT00004500Phase 3
6Inhaled Nitric Oxide Study for Respiratory Failure in NewbornsTerminatedNCT00005776Phase 3
7Early Inhaled Nitric Oxide for Respiratory Failure in NewbornsTerminatedNCT00005773Phase 3
8Inhaled PGE1 in Neonatal Hypoxemic Respiratory FailureWithdrawnNCT00598429Phase 2
9Effect Of Intrapartum Oropharyngeal (IP-OP) Suction on Meconium Aspiration SyndromeCompletedNCT01328483
10Comparison Of Surfactant Lung Lavage With Standard Care In The Treatment Of Meconium Aspiration SyndromeCompletedNCT01310621
11Use of Heliox in the Management of Neonates With Meconium Aspiration SyndromeCompletedNCT01274845
12Role of Endotracheal Suction on the Occurrence of Meconium Aspiration Syndrome in Non-vigorous Meconium Stained BabiesCompletedNCT01758822
13Antibody Secreting Cell and Cyotokine Profiles in Neonates on ECMOCompletedNCT00371241
14Post Term Pregnancy - Induction of Labor or Monitoring of PregnancyCompletedNCT00385229
15Effect of Gastric Lavage in Preventing Feeding Problems in Babies Born With Meconium Stained Amniotic FluidCompletedNCT01306500
16Helium Oxygen Mixture in the Treatment of Meconium Aspiration SyndromeRecruitingNCT02620891
17Role and Molecular Mechanism of Farnesoid X Receptor(FXR) and RIPK3 in the Formation of Acute Respiratory Distress Syndrome in NeonatesRecruitingNCT02598648
18Meconium Aspiration and Tracheal Suctioning—Feasibility StudyNot yet recruitingNCT02708563
19High Flow Ventilation With Volume GuaranteeNot yet recruitingNCT02571231
20Efficacy and Safety of Gastric Suctioning During Neonatal ResuscitationNot yet recruitingNCT00729989

Search NIH Clinical Center for Meconium Aspiration Syndrome


Cochrane evidence based reviews: meconium aspiration syndrome

Genetic Tests for Meconium Aspiration Syndrome

About this section

Anatomical Context for Meconium Aspiration Syndrome

About this section

MalaCards organs/tissues related to Meconium Aspiration Syndrome:

33
Lung, Uterus, T cells, Endothelial, Bone, Pituitary, Thyroid

Animal Models for Meconium Aspiration Syndrome or affiliated genes

About this section

MGI Mouse Phenotypes related to Meconium Aspiration Syndrome:

38
idDescriptionMGI Source AccessionScoreTop Affiliating Genes

Publications for Meconium Aspiration Syndrome

About this section

Articles related to Meconium Aspiration Syndrome:

(show top 50)    (show all 277)
idTitleAuthorsYear
1
Recurrent Jarisch-Herxheimer reaction in late latent syphilis. (26834029)
2016
2
A rare case of familial multiple subcutaneous lipomatosis with novel PALB2 mutation and increased predilection to cancers. (26845227)
2016
3
First report of junctional epidermolysis bullosa (JEB) in the Italian draft horse. (25889423)
2015
4
Association between the NFKB1-94ins/del ATTG polymorphism and cancer risk: an updated meta-analysis. (24827594)
2014
5
Classification and regression tree (CART) analysis of endometrial carcinoma: Seeing the forest for the trees. (23774300)
2013
6
Characterisation of mumps virus genotype C among patients with mumps in India. (23883719)
2013
7
Clinical significance of pulmonary nodules detected by CT and Not CXR in patients treated for favorable histology Wilms tumor on national Wilms tumor studies-4 and -5: a report from the Children's Oncology Group. (22422736)
2012
8
Sympathetic nerves bridge the cross-transmission in hemifacial spasm. (22531749)
2012
9
Mycobacterium tuberculosis lipoproteins directly regulate human memory CD4(+) T cell activation via Toll-like receptors 1 and 2. (21078852)
2011
10
ID1 enhances docetaxel cytotoxicity in prostate cancer cells through inhibition of p21. (20388787)
2010
11
A rare case of primary mucinous cystadenoma of spleen. (22461876)
2009
12
Increased frequency of CD16+ monocytes and the presence of activated dendritic cells in salivary glands in primary SjAPgren syndrome. (18397959)
2009
13
Eyelid opening apraxia in an AIDS patient. (18067181)
2008
14
Management of diabetic ketoacidosis in children and adolescents. (19047433)
2008
15
Hypohidrotic ectodermal dysplasia. (19061621)
2008
16
The murine pan T cell marker CD96 is an adhesion receptor for CD155 and nectin-1. (17971293)
2007
17
Improved quantitative method for G6PD deficiency detection. (17385678)
2007
18
SCAM analysis reveals a discrete region of the pore turret that modulates slow inactivation in Kv1.5. (16956964)
2007
19
The dynamism of PABPN1 nuclear inclusions during the cell cycle. (16860991)
2006
20
Chemerin activation by serine proteases of the coagulation, fibrinolytic, and inflammatory cascades. (16096270)
2005
21
Role of CCR8 and other chemokine pathways in the migration of monocyte-derived dendritic cells to lymph nodes. (15534368)
2004
22
Human models of endotoxemia and recombinant human activated protein C. (15118518)
2004
23
Lymph node fibroblastic reticular cells construct the stromal reticulum via contact with lymphocytes. (15381731)
2004
24
Interactions between the nitric oxide and prostaglandin E2 biosynthetic pathways in human amnion-like WISH cells. (14568676)
2003
25
Obstructive anuria due to fungal bezoars in a renal graft recipient. (14612076)
2003
26
Esophageal actinomycosis. (12602734)
2003
27
Involvement of the SREBP pathway in the mode of action of androgens in sebaceous glands in vivo. (12930306)
2003
28
Pseudomyxoma peritonei of appendiceal cancer with metastasis to the stomach: report of a case. (12107784)
2002
29
Calmodulin-binding and autoinhibitory domains of Acanthamoeba myosin I heavy chain kinase, a p21-activated kinase (PAK). (11579107)
2001
30
The response of human breast tumour cell lines with altered polymerase beta levels to cisplatin and radiation. (11497301)
2001
31
The cell-cycle regulatory protein Cks1 is required for SCF(Skp2)-mediated ubiquitinylation of p27. (11231585)
2001
32
Signal-dependent and -independent degradation of free and NF-kappa B-bound IkappaBalpha. (10801847)
2000
33
A novel zinc finger protein mRNA in human umbilical vein endothelial cells is profoundly induced by tumor necrosis factor alpha. (11426589)
2000
34
Molecular characterization of a human scavenger receptor, human MARCO. (10651831)
2000
35
Effects of vigabatrin on the GABAergic system as determined by [123I]iomazenil SPECT and GABA MRS. (10528940)
1999
36
Localization of matrix metalloproteinases and tissue inhibitor of metalloproteinases-2 in normal human and rabbit stomachs. (10343138)
1999
37
Inhibition of NF-kappaB potentiates amyloid beta-mediated neuronal apoptosis. (10430956)
1999
38
Muscular intolerance of exercise. Current data]. (9834785)
1998
39
Nitric oxide suppression of apoptosis occurs in association with an inhibition of Bcl-2 cleavage and cytochrome c release. (9813055)
1998
40
Progress in population analyses of the insulin resistance syndrome. (9329738)
1997
41
Lymphocytic adenohypophysitis and neurohypophysitis. (9187559)
1997
42
Acute traumatic central cord syndrome: MRI-pathological correlations. (1603319)
1992
43
Molecular structure of rat hepatic 3 alpha-hydroxysteroid dehydrogenase. A member of the oxidoreductase gene family. (1714456)
1991
44
Mycotic vaginitis in pregnancy: a double evaluation of the susceptibility to the main antimycotic drugs of isolated species. (3513850)
1986
45
Myositis ossificans following forcible manipulation of the leg. A rabbit model for the study of heterotopic bone formation. (7391105)
1980
46
Pulmonary geotrichosis and candidiasis. (5113696)
1971
47
THE USE OF ADDITIONAL LEADS IN THE EARLY DIAGNOSIS OF POSTERIOR MYOCARDIAL INFARCTION. (14335327)
1965
48
Juvenile laryngeal papillomatosis. The relation of radiation to malignant degeneration in this disease. (5296305)
1965
49
Prolonged anuria treated by infusion into the vena cava. (13222856)
1955
50
Pellagra and its relation to pituitary supra-renal cortical system. (14393205)
1955

Variations for Meconium Aspiration Syndrome

About this section

Expression for genes affiliated with Meconium Aspiration Syndrome

About this section
Search GEO for disease gene expression data for Meconium Aspiration Syndrome.

Pathways for genes affiliated with Meconium Aspiration Syndrome

About this section

Pathways related to Meconium Aspiration Syndrome according to GeneCards Suite gene sharing:

idSuper pathwaysScoreTop Affiliating Genes
19.8EDN1, SCGB1A1
29.0PLA2G10, PLA2G2A
39.0PLA2G10, PLA2G2A
4
Show member pathways
9.0PLA2G10, PLA2G2A

GO Terms for genes affiliated with Meconium Aspiration Syndrome

About this section

Biological processes related to Meconium Aspiration Syndrome according to GeneCards Suite gene sharing:

(show all 7)
idNameGO IDScoreTop Affiliating Genes
1response to dexamethasoneGO:007154810.1CPS1, EDN1
2response to ozoneGO:001019310.0EDN1, SCGB1A1
3phosphatidylinositol acyl-chain remodelingGO:00361499.6PLA2G10, PLA2G2A
4positive regulation of macrophage derived foam cell differentiationGO:00107449.4PLA2G10, PLA2G2A
5lipid catabolic processGO:00160429.4PLA2G10, PLA2G2A
6response to lipopolysaccharideGO:00324969.3CPS1, EDN1, SCGB1A1
7phospholipid metabolic processGO:00066449.1PLA2G10, PLA2G2A

Sources for Meconium Aspiration Syndrome

About this section
2CDC
14ExPASy
15FDA
16FMA
24GTR
25HGMD
26HMDB
27ICD10
28ICD10 via Orphanet
29ICD9CM
30IUPHAR
31KEGG
34MedGen
36MeSH
37MESH via Orphanet
38MGI
41NCI
42NCIt
43NDF-RT
46NINDS
47Novoseek
49OMIM
50OMIM via Orphanet
54PubMed
55QIAGEN
60SNOMED-CT via Orphanet
64Tumor Gene Family of Databases
65UMLS
66UMLS via Orphanet